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Abstract
Purpose: The purpose of this study was to investigate the effects of obesity and aerobic exercise training on oxidant-antioxidant balance,
neurotrophic factor levels, and blood–brain barrier (BBB) function.
Methods: Ten non-obese healthy men (body mass index < 25 kg/m2) and 10 obese men (body mass index ≥ 25 kg/m2) were included in the study.
Both groups performed treadmill exercise for 40 min 3 times weekly for 8 weeks at 70% heart rate reserve. Blood samples were collected to
examine oxidant-antioxidant balance (reactive oxygen species (ROS) and superoxide dismutase (SOD) activity levels), neurotrophic factors
(brain-derived neurotrophic factor (BDNF), nerve growth factor, and glial cell line-derived neurotrophic factor levels), and BBB function (S100β
and neuron-specific enolase (NSE) levels) before and after exercise training.
Results: The obese group showed significantly greater changes than the non-obese group in serum ROS (−0.46 ± 0.31 mmol/L vs. −0.10 ±
0.17 mmol/L, p = 0.005), serum S100β levels (−8.50 ± 5.92 ng/L vs. −0.78 ± 5.45 ng/L, p = 0.007), and serum NSE levels (−0.89 ± 0.54 μg/L vs.
−0.01 ± 0.74 μg/L, p = 0.007) after training. At baseline, the obese group showed significantly higher serum ROS and S100β levels and significantly
lower serum SOD activity and BDNF levels than the non-obese group (p < 0.05). The obese group showed significantly lower serum ROS, S100β,
and NSE levels and significantly higher serum SOD activity and BDNF levels after training compared with the non-obese group (p < 0.05).
Conclusion: These results suggest that obesity can reduce serum neurotrophic factor levels and can induce BBB dysfunction. On the other hand,
aerobic exercise can improve an oxidant-antioxidant imbalance in obese subjects and limit BBB dysfunction.
© 2016 Production and hosting by Elsevier B.V. on behalf of Shanghai University of Sport. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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1. Introduction
Oxygen is essential to life and physical activity, but it gen-
erates toxic reactive oxygen species (ROS) when incompletely
reduced.1,2 These ROS include hydroxyl radical (HO·), hydro-
gen peroxide, and superoxide radical ( O2
i−).2,3 Obesity has been
shown to induce oxidative stress and increase ROS by creating
an imbalance between pro-oxidants and antioxidants.4,5
Obesity is associated with excessive free fatty acid (FFA)
levels and hyperglycemia. The excess FFAs are shunted into the
citric acid cycle, increasing acetyl-CoA levels and producing
nicotinamide adenine dinucleotide dehydrogenase (NADH). A
sudden infusion of FFAs into the body causes an increase
in isoprostane levels, a marker of lipid peroxidation and a
by-product of cell damage from increased ROS activity.6
Moreover, increased glucose metabolism by intracellular
hyperinsulinemia causes an excessive production of NADH and
flavin adenosine dinucleotide, which are used in the electron
transport chain to create adenosine triphosphate.7 The mito-
chondrial proton gradient increases with excessive NADH,
resulting in the creation of superoxide radicals through the
transfer of a proton to oxygen. This results in oxidative stress in
various organisms.5,8 Several studies have reported that obese
subjects have significantly higher levels of thiobarbituric acid
reactive substances, which are markers of plasma oxidative
stress.9,10 They also have significantly decreased glutathione
peroxidase and copper-zinc SOD activities,10,11 worsening oxi-
dative stress.
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The resulting oxidative stress induces DNA denaturation
and apoptosis,12 causing cardiovascular disease, diabetes, cancer,
and neurodegenerative diseases.13,14 In particular, the brain
contains significant amounts of unsaturated fatty acid and
circulating oxygen but has decreased antioxidant enzyme activ-
ity compared with other organs, increasing the risk for the
development of neurodegenerative diseases through the apop-
tosis of vulnerable neurons.15,16 Moreover, the brain’s blood
vessels comprise a blood–brain barrier (BBB) composed of
tight junctions, pericytes, astrocyte end-feet, and basal lamina.
The BBB protects the brain from sudden changes in blood
components by selectively blocking toxic substances that threaten
normal brain function.17 However, excessive oxidative stress
can damage the BBB18,19 and result in various neurologic
diseases.20
Benedict et al.21 reported that increased peripheral blood
levels of neuron-specific enolase (NSE) and S100β, circulating
brain-specific proteins, may be indicative of neuronal damage,
impaired BBB function, or both. Moreover, obesity regulates
neuronal survival, plasticity, and neurotransmitter release
and is related to brain-derived neurotrophic factor (BDNF)
expression, which can prevent cognitive dysfunction and
neurodegenerative diseases.22 Gardiner et al.23 suggested that
an increase in oxidative stress can be linked with the
downregulation of this neurotrophic factor.
On the other hand, regular exercise training is an effective
treatment for obesity that reduces oxidative stress caused by
obesity or diseases such as metabolic syndrome24 and induces
an increase in neurotrophic factors.25 However, previous human
studies have been limited to the measurement of only BDNF,
nerve growth factor (NGF), and glial cell line-derived neuro-
trophic factor (GDNF).
As noted earlier, regular exercise training can alleviate oxi-
dative stress in obese subjects and can affect neurotrophic
factor levels, which promote brain cell growth and support the
BBB protecting the brain. However, no previous study has
determined the relationship between regular exercise training,
oxidative stress, BDNF levels, and BBB damage. Thus, this
study aimed to investigate the effects of regular exercise train-
ing on the oxidant–antioxidant balance, neurotrophic factor
levels, and BBB function in obese subjects.
2. Methods
2.1. Subjects
Subjects included in this study did not participate in regular
exercise and understood the purpose of this study. We included
2 groups: 10 healthy non-obese males with a body mass index
(BMI) < 25 kg/m2 and 10 obese males with a BMI > 25 kg/m2
based on the World Health Organization/International Associa-
tion for the Study of Obesity/International Obesity Task Force
definition of obesity.26 The subjects did not take any medication,
and no dietary modifications were made during the study. The
subjects were informed about data collection and purposes of
the study, and all subjects agreed to participate, signing a
written informed consent statement. The protocol of this study
was approved by the National Research Foundation of Korea
(NRF-2013S1A5B5A07049580), and the physical characteris-
tics of the subjects are shown in Table 1.
2.2. Anthropometric measurements
Anthropometric measurements including height, weight,
BMI, percentage of fat, resting blood pressure (BP), resting
heart rate (HR), and maximum oxygen uptake (VO2max) were
obtained. Height was measured using semiautomatic height
measurement equipment (HD; STDK, Tokyo, Japan), and
weight and body composition were measured using a
bioelectrical impedance analysis body composition analyzer
(Inbody220; Biospace, Seoul, Korea). Resting BP in the bra-
chial artery was obtained by a nurse with a mercury sphygmo-
manometer (Trimline; PyMaH, Somerville, NJ, USA) after
subjects had relaxed in a comfortably seated position for at least
10 min. The HR was measured with a wireless HR analyzer
(Polar A5; Polar, Kempele, Finland). VO2max was measured on
the treadmill (Q65; Quinton, Seattle, WA, USA) at 1.7 mph and
a 10% grade using the Bruce protocol with an increase of
0.8–0.9 mph and 2% grade every 3 min.27 Breath-by-breath
analysis was applied using a gas analyzer (Metamax 3B;
Cortex, Leipzig, Germany) and a wireless HR analyzer (Polar
A5). Repeat measurements of weight, body composition,
resting BP, resting HR, and VO2max were conducted after 8
weeks of training to record changes in obesity and cardiovas-
cular parameters.
2.3. Exercise training method
Running exercise was performed on a treadmill 3 times
weekly for 8 weeks in accordance with a previously described
training method28 and exercise prescription guidelines for obese
subjects.29 Exercise intensity was set at 70%HR reserve using
the Karvonen formula, in which the resting HR (HRrest) and
maximum HR (HRmax) are measured during the VO2max test.30
Exercise intensity during training was controlled at a ±5% error
range of the target HR using the wireless HR analyzer (Polar
A5). Exercise duration was 60 min, including 10 min warm-up
(stretching) and cool-down periods (stretching) and 40 min of
treadmill exercise.
Table 1






Age (year) 22.80 ± 2.35 23.00 ± 2.36 0.851
Height (cm) 173.90 ± 3.75 173.20 ± 4.56 0.712
Weight (kg) 66.63 ± 3.60 89.25 ± 10.71 <0.001
BMI (kg/m2) 22.00 ± 1.22 29.74 ± 3.12 <0.001
Body fat (%) 14.56 ± 3.29 29.60 ± 4.37 <0.001
Resting SBP (mmHg) 117.50 ± 4.60 124.70 ± 5.08 0.004
Resting DBP (mmHg) 74.50 ± 6.10 83.10 ± 7.52 0.012
Resting HR (beats/min) 65.90 ± 2.73 73.90 ± 3.93 <0.001
VO2max (mL/kg/min) 55.35 ± 3.10 41.34 ± 7.36 <0.001
* Determined using the independent t test.
Abbreviations: BMI = body mass index; DBP = diastolic blood pressure;
HR = heart rate; SBP = systolic blood pressure; VO2max = maximum oxygen
uptake.
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2.4. Blood collection and analysis methods
In all, 10 mL of blood was collected from the antecubital
vein with a 22-gauge needle and serum separator tubes before
and after 8 weeks of training. The blood separation was per-
formed by centrifugation at 3000 rpm for 15 min, and serum
was kept at −80°C until the analysis of serum oxidant-
antioxidant status (ROS and SOD), neurotrophic factors
(BDNF, NGF, and GDNF), and BBB function-related factors
(S100β and NSE) was performed.
2.5. Blood oxidant–antioxidant marker analysis methods
The analysis of serum ROS was conducted using the
OxiSelect In Vitro ROS/RNS Assay Kit (#STA-347;
Cell Biolabs, San Diego, CA, USA). In this assay
2′,7′-dichlorodihydrofluorescein is converted to 2′,7′-
dichlorodihydrofluorescein diacetate by ROS. Fluorescence
was measured at 480 nm and 530 nm using a fluorescence plate
reader (LS 55 Luminescence Spectrometer; PerkinElmer,
Waltham, MA, USA). The analysis of serum SOD activity was
performed using a colorimetric assay with the Superoxide
Dismutase Assay Kit (#CM706002; IBL International,
Hamburg, Germany) at 450 nm with a microplate reader
(GENios; TECAN, Salzburg, Austria).
2.6. Blood neurotrophic factor analysis methods
Serum BDNF, NGF, and GDNF levels were measured using
sandwich enzyme-linked immunosorbent assays (ELISAs). For
BDNF, we used the Human BDNF ELISA Kit (#DBD00; R&D
Systems, Minneapolis, MN, USA); for NGF we used the NGF
sandwich ELISA Kit (#CYT304; ChemiKine, Temecula, CA,
USA), and for GDNF we used the GDNF Human ELISA Kit
(#ab100525; Abcam, Cambridge, MA, USA). Fluorescence
was measured at 450 nm with a microplate reader (Emax;
Molecular Devices, Sunnyvale, CA, USA).
2.7. BBB function-related marker analysis methods
Serum S100β levels were measured with a S100β (Human)
ELISA Kit (#KA0037; Abnova, Taiwan, China), and NSE
levels were measured with a Human NSE ELISA Kit (#M-
0050; Alpha Diagnostic International, San Antonio, TX, USA).
Florescence was measured at 450 nm with a microplate reader
(Emax) with ELISA.
2.8. Statistical analysis
The data from this study are expressed as mean ± SD using
SPSS/PC+ Ver. 21.0 for Windows (IBM, Armonk, NY, USA).
Two-way repeated analysis of variance (ANOVA) was con-
ducted to examine the differences in each dependent variable
and group before and after exercise training. An independent t
test was conducted to examine the differences between the
obese and non-obese groups prior to training. Statistical sig-
nificance (α) was set at 0.05.
3. Results
3.1. Changes in body composition and cardiovascular
parameters
Changes in body composition (weight, BMI, and percentage
of fat) and cardiovascular parameters (BP, HR, and VO2max) in
the non-obese and obese groups before and after aerobic exer-
cise training are shown in Table 2. The 2-way repeated ANOVA
for body composition and VO2max showed an interaction
effect in weight (F = 16.474, p = 0.001), BMI (F = 18.384,
p < 0.001), percentage of fat (F = 18.384, p < 0.001), and
VO2max (F = 12.292, p = 0.003), which showed significant
differences. There were no significant differences in resting
systolic blood pressure (F = 0.485, p = 0.495), diastolic blood
pressure (F = 1.427, p = 0.248), and HR (F = 1.458, p = 0.243).
The post hoc test results revealed that the non-obese group did
not show significant differences in these parameters before and
after training, but the obese group showed significantly lower
weight, BMI, and percentage of fat (all p < 0.05) and a signifi-
cantly higher VO2max (p < 0.05) after training. Moreover, the
obese group showed a significantly higher weight, BMI, and
percentage of fat and a significantly lower VO2max before and
after training compared with the non-obese group (all p < 0.05).
3.2. Changes in blood oxidant–antioxidant balance
Changes in the oxidant–antioxidant balance in the nonobese
and obese groups before and after aerobic exercise training are
shown in Table 3. The 2-way repeated ANOVA revealed
Table 2
Changes in body composition and cardiovascular assessments before and after training (mean ± SD).
Variables Non-obese (n = 10) Obese (n = 10) Time × group interaction
Baseline CV After training CV Baseline CV After training CV F p
Weight (kg) 66.63 ± 3.60 0.05 66.43 ± 3.70 0.06 89.25 ± 10.71* 0.12 84.36 ± 12.11*,# 0.14 16.474 0.001
BMI (kg/m2) 22.00 ± 1.22 0.06 21.87 ± 1.24 0.06 29.74 ± 3.12* 0.11 27.95 ± 3.30*,# 0.12 18.384 <0.001
Body fat (%) 14.56 ± 3.29 0.23 13.98 ± 3.12 0.22 29.60 ± 4.37* 0.15 26.59 ± 4.97*,# 0.19 18.384 <0.001
Resting SBP (mmHg) 117.50 ± 4.60 0.04 117.40 ± 4.40 0.04 124.70 ± 5.08 0.04 123.10 ± 5.40 0.04 0.485 0.495
Resting DBP (mmHg) 74.50 ± 6.10 0.08 73.10 ± 4.56 0.06 83.10 ± 7.52 0.09 79.10 ± 6.24 0.08 1.427 0.248
Resting HR (beats/min) 65.90 ± 2.73 0.04 65.10 ± 3.00 0.05 73.90 ± 3.93 0.05 71.50 ± 3.57 0.05 1.458 0.243
VO2max (mL/kg/min) 55.35 ± 3.10 0.06 55.98 ± 3.48 0.06 41.34 ± 7.36* 0.18 46.98 ± 8.14*,# 0.17 12.292 0.003
* p < 0.05, compared with corresponding values in non-obese group; # p < 0.05, compared with baseline values within obese group.
Abbreviations: BMI = body mass index; CV = coefficient of variation; DBP = diastolic blood pressure; HR = heart rate; SBP = systolic blood pressure;
VO2max = maximum oxygen uptake.
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significant differences in blood ROS levels and SOD activity
between the 2 groups before and after training (F = 10.209,
p = 0.005; F = 9.502, p = 0.006, respectively). The post hoc test
results showed that the obese group had significantly higher
ROS levels and lower SOD activity at baseline compared with
the non-obese group (both p < 0.05). In addition, the non-obese
group showed no significant differences in these values before
and after training, whereas the obese group showed signifi-
cantly decreased ROS levels and increased SOD activity after
training (both p < 0.05).
3.3. Changes in blood neurotrophic factor levels
Changes in blood neurotrophic factor levels in the non-obese
and obese groups before and after aerobic exercise training are
shown in Table 4. The 2-way repeated ANOVA showed inter-
action effects for blood BDNF before and after training, indi-
cating a significant difference (F = 7.665, p = 0.013). There
were no significant differences in blood NGF and GDNF levels
(F = 1.802, p = 0.196; F = 1.854, p = 0.190, respectively).
According to the post hoc test results, the obese group showed
a significantly lower BDNF level at baseline compared with the
non-obese group (p < 0.05). In addition, the non-obese group
showed no significant difference in blood neurotrophic factor
levels before and after training, whereas the obese group
showed a significantly higher BDNF level after training
(p < 0.05).
3.4. Changes in serum BBB function markers
Changes in serum BBB function markers in the non-obese
and obese groups before and after aerobic exercise training are
shown in Table 5. The 2-way ANOVA showed interaction
effects for blood S100β and NSE levels before and
after training, indicating significant differences (F = 9.202,
p = 0.007; F = 9.271, p = 0.007, respectively). According to the
post hoc test results, the obese group showed significantly
higher S100β levels at baseline compared with the non-obese
group (p < 0.05). Furthermore, the non-obese group showed no
significant differences before or after training, whereas the
obese group showed significantly lower S100β levels and NSE
levels after training (both p < 0.05).
4. Discussion
Regular exercise, along with dietary control, is effective in
the prevention of obesity.31 In our study, body composition
parameters including weight, BMI, and percentage of fat were
significantly reduced in the obese group after training, indicat-
ing a positive effect of training on obesity reduction. In addi-
tion, the obese group showed a significantly increased VO2max,
whereas the non-obese group showed no significant change in
VO2max with training. We believe this occurred because the
VO2max of the non-obese group was in the upper 10th percentile
before training (VO2max > 51.4 mL/kg/min),32 and therefore a
Table 3
Changes in blood oxidant–antioxidant status before and after training (mean ± SD).
Variables Non-obese (n = 10) Obese (n = 10) Time × group interaction
Baseline CV After training CV Baseline CV After training CV F p
ROS (mmol/L) 1.52 ± 0.34 0.23 1.41 ± 0.23 0.16 1.90 ± 0.34* 0.18 1.43 ± 0.26# 0.18 10.209 0.005
SOD (U/mL) 2.76 ± 0.53 0.19 2.83 ± 0.50 0.18 2.10 ± 0.72# 0.34 2.76 ± 0.58# 0.21 9.502 0.006
* p < 0.05, compared with baseline values in non-obese group; # p < 0.05, compared with baseline values within obese group.
Abbreviations: CV = coefficient of variation; ROS = reactive oxygen species; SOD = superoxide dismutase.
Table 4
Changes in blood neurotrophic factor levels before and after training (mean ± SD).
Variables Non-obese (n = 10) Obese (n = 10) Time × group interaction
Baseline CV After training CV Baseline CV After training CV F p
BDNF (pg/mL) 29,777.40 ± 3243.85 0.11 30,121.62 ± 2974.32 0.10 24,501.20 ± 3951.45* 0.16 29,508.34 ± 4817.02# 0.16 7.665 0.013
NGF (pg/mL) 373.60 ± 39.28 0.11 398.94 ± 22.96 0.06 366.99 ± 35.66 0.10 373.81 ± 14.98 0.04 1.802 0.196
GDNF (pg/mL) 634.96 ± 111.78 0.18 650.17 ± 89.54 0.14 586.05 ± 64.44 0.11 638.42 ± 76.41 0.12 1.854 0.190
* p < 0.05, compared with the baseline value in non-obese group; # p < 0.05, compared with the baseline value within obese group.
Abbreviations: BDNF = brain-derived neurotrophic factor; CV = coefficient of variation; GDNF = glial cell line-derived neurotrophic factor; NGF = nerve growth
factor.
Table 5
Changes in blood blood-brain barrier function markers before and after training (mean ± SD).
Variables Non-obese (n = 10) Obese (n = 10) Time × group interaction
Baseline CV After training CV Baseline CV After training CV F p
S100β (ng/L) 49.03 ± 11.83 0.24 48.25 ± 9.69 0.20 63.20 ± 14.56* 0.23 54.70 ± 10.47# 0.19 9.202 0.007
NSE (μg/L) 5.99 ± 1.13 0.19 5.98 ± 1.09 0.18 6.87 ± 0.90 0.13 5.98 ± 0.87# 0.14 9.271 0.007
* p < 0.05, compared with the baseline value in non-obese group; # p < 0.05, compared with baseline values within obese group.
Abbreviations: CV = coefficient of variation; NSE = neuronspecific enolase.
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greater exercise effort was required to promote cardiorespira-
tory fitness in the non-obese group.
Oxidative stress occurs when pro-oxidants are predominant
compared with antioxidants,33 and it has been reported that
obesity is associated with chronically increased oxidative
stress.24 In this study, the obese group had a significantly higher
ROS level and significantly lower SOD activity at baseline
compared with the non-obese group. This result supports pre-
vious studies reporting that obese subjects show a higher pro-
oxidant/antioxidant ratio compared with that of normal-weight
subjects34 and implies that obesity can increase oxidative stress.
On the other hand, ROS levels decreased and SOD activity
levels increased significantly in the obese group after training.
It is assumed that exercise training improved the antioxidant
balance in the obese group as well as significantly decreasing
weight and BMI. Vincent and Taylor5 reported that obesity
induces an imbalance in pro-oxidant–antioxidant imbalance by
depleting enzymatic antioxidants such as SOD, but that exercise
training increases antioxidant status, and weight loss amelio-
rates increased oxidative stress in obese subjects. In addition,
according to a large epidemiologic study, obesity is highly
associated with BMI and oxidative stress, supporting the results
of this study.35 Moreover, high blood glucose levels may be
associated with obesity and increased oxidative stress, but
glucose levels were not assessed in this study. This is a limita-
tion of our study, and future studies should examine the asso-
ciation between glucose levels, exercise training, and oxidative
stress.
Recent studies have reported that obesity can increase
the body’s oxidative stress. High oxidative stress reduces
neurotrophic factor levels, has a negative impact on brain func-
tion, and is related to the occurrence of neurodegenerative
diseases.36,37 In this study, we analyzed serum BDNF, NGF, and
GDNF levels to examine the effects of obesity and exercise
training on neurotrophic factor levels. The obese group showed
significantly lower serum BDNF levels at baseline compared
with those of the non-obese group, but BDNF levels in the
obese group increased significantly after exercise training. This
result supports those of previous studies, which reported that
obese and overweight subjects showed significantly lower
serum BDNF levels compared with normal-weight subjects38,39
and that aerobic exercise training significantly increased serum
BDNF levels in obese subjects.39,40 The changes in serum ROS
levels and SOD activity in this study indicate that the reduced
oxidative stress and improved antioxidant ability with exercise
training can significantly affect BDNF levels. Increased oxida-
tive stress levels can downregulate neurotrophic factors,23 and
BDNF has shown a negative correlation with oxidative stress
and a positive correlation with antioxidant activity.41,42 More-
over, recent studies have shown improved antioxidant activity
with regular exercise and that the use of various antioxidants
can promote the expression of neurotrophic factors,43-45 sup-
porting the results of this study. On the other hand, there was a
significant difference in BDNF levels between the obese and
non-obese groups at baseline. The obese group showed signifi-
cant increases in BDNF after training, but no increase was
observed in NGF and GDNF levels. These results support those
of a previous study reporting that exercise training significantly
increased hippocampal BDNF mRNA expression but not NGF
and GDNF mRNA expression in rats.46 NGF, GDNF, and
BDNF levels play an important role in the survival, mainte-
nance, and regeneration of a specific neuronal population.47
BDNF also plays an important role in the central and peripheral
molecular processes of energy metabolism and homeostasis.45,48
Additional studies are needed to determine the effects of calorie
restriction on these neurotrophic factors.
The BBB is a multicellular vascular structure that separates
the central nervous system from the peripheral blood circula-
tion. The BBB actively regulates influx and efflux at the blood–
brain interface.49 A disruption of the BBB may play a role in the
etiology of various cerebrovascular and nervous diseases such
as ischemic stroke, epilepsy, amyotrophic lateral sclerosis, and
neuromyelitis optica.49 Thus, the maintenance of BBB function
is important for long-term brain health. In this study, we mea-
sured serum S100β and NSE levels to examine the effects of
obesity and exercise training on BBB function. The obese group
showed significantly higher serum S100β levels at baseline
(63.20 ± 14.56 ng/L) compared with those of the non-obese
group (49.03 ± 11.83 ng/L). This correlation between obesity
and serum S100β levels was similar to that reported by Steiner
et al.,50 who showed that overweight subjects with a BMI of
25–29.9 kg/m2 showed significantly higher serum S100β levels
(about 60 ng/L) compared with control subjects (about
50 ng/L) with a BMI of 25 kg/m2. Also, S100β and NSE levels
were significantly reduced in the obese group after exercise
training. These results show that obesity exacerbates BBB dys-
function by increasing oxidative stress, but exercise training
reduces ROS levels and increases SOD activity. Microglia acti-
vation, the upregulation of proinflammatory cytokines, and an
increase in oxidative stress largely account for the obesity-
induced BBB disruption.18 However, antioxidants such as
catalase and SOD have been shown to attenuate the BBB
hyperpermeability resulting from hyperglycemia.51 Schulpis
et al.52 reported a negative correlation between serum S100β
levels and total antioxidant status (r = −0.64). Moreover,
Al-Jarrah and Jamous53 previously reported that treadmill exer-
cise training decreased S100β and NSE expression in a Parkin-
son disease mouse model, supporting the results of this study.
In addition, even though serum S100β and NSE levels are blood
biomarkers for BBB disruption and a BBB permeability
increase,21,54 future studies analyzing circulating tight junction
proteins and matrix metalloproteinases may more specifically
reflect BBB function because S100β is expressed in various
peripheral tissues, including skeletal muscle, and NSE reflects
brain damage.55,56
5. Conclusion
In conclusion, obesity can reduce serum neurotrophic factor
levels and induce BBB dysfunction. Increased oxidative stress
caused by obesity is largely responsible for this phenomenon.
On the other hand, regular aerobic exercise can improve the
oxidant–antioxidant imbalance resulting from obesity, increase
neurotrophic factor levels, and limit BBB dysfunction.
However, future studies should investigate calorie restriction
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because neurotrophic factors, such as BDNF, are also involved
in energy metabolism,45,48 and serum S100β levels show a high
correlation with changes in weight.50
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